1 drug(s) with this reaction
1,351 total reports
Off Label Use has been reported as an adverse reaction across 1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,351 adverse event reports mention off label use in connection with Ipsen Biopharmaceuticals Inc products.
This page provides a breakdown of which Ipsen Biopharmaceuticals Inc drugs are most commonly associated with off label use, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Ipsen Biopharmaceuticals Inc drugs have off label use listed in their FDA adverse event reports, sorted by report count:
In addition to off label use, the following adverse reactions have been reported across Ipsen Biopharmaceuticals Inc's drug portfolio:
1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc have off label use listed in their FDA adverse event reports: LANREOTIDE ACETATE.
There are a combined 1,351 reports of off label use across 1 Ipsen Biopharmaceuticals Inc drug(s) in the FDA adverse event database.